Literature DB >> 12631614

Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

Kuniaki Nakanishi1, Toshiaki Kawai, Fumiyuki Kumaki, Sadayuki Hiroi, Makio Mukai, Eiji Ikeda, Catherine Elaine Koering, Eric Gilson.   

Abstract

PURPOSE AND EXPERIMENTAL
DESIGN: It has been suggested that atypical adenomatous hyperplasia (AAH) may be a precursor of peripheral adenocarcinoma of the lung. Telomerase is a ribonucleoprotein enzyme that synthesizes telomeric DNA onto chromosomal ends. Its activity is thought to participate in the development of most human cancers. Telomere-specific DNA-binding proteins, such as telomeric repeat binding factor 1 and telomeric repeat binding factor 2, also control telomere length in a complex interplay with telomerase. Here we investigated the expressions of the mRNAs encoded by the TERF1 and TERF2 genes using in situ hybridization in surgically resected specimens [28 AAHs (11 lesions were interpreted as low-grade AAH, and 17 were interpreted as high-grade AAH) and 40 peripherally located bronchioloalveolar carcinoma (BAC).
RESULTS: A clear overexpression of these mRNAs was recognized in low- and high-grade AAH and BAC samples (as compared with normal tissues) using in situ hybridization and these mRNAs were detected in normal AAH and BAC samples using reverse transcription-PCR. The expressions of TERF1 and TERF2 mRNA detected by in situ hybridization were scored positive in 36% and 82% of low-grade AAH, 65% and 83% of high-grade AAH, and 88% and 88% of BAC, respectively. Statistically significant differences in TERF1 mRNA expression could be shown between low-grade AAH and BAC and between high-grade AAH and BAC. There was no statistical difference in the positive expressions of TERF2 mRNA among low-grade AAH, high-grade AAH, and BAC.
CONCLUSIONS: These results are consistent with (but are not enough to confirm) the idea that high-grade AAH is closely related to BAC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631614

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  31 in total

1.  Crystal structure of a tankyrase 1-telomere repeat factor 1 complex.

Authors:  Bo Li; Ruihong Qiao; Zhizhi Wang; Weihong Zhou; Xin Li; Wenqing Xu; Zihe Rao
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-03-24       Impact factor: 1.056

2.  Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway.

Authors:  Irmina Diala; Nicole Wagner; Frédérique Magdinier; Marina Shkreli; Maria Sirakov; Serge Bauwens; Caroline Schluth-Bolard; Thomas Simonet; Valérie M Renault; Jing Ye; Abdelnnadir Djerbi; Pascal Pineau; Jinkuk Choi; Steven Artandi; Anne Dejean; Michelina Plateroti; Eric Gilson
Journal:  EMBO Rep       Date:  2013-02-22       Impact factor: 8.807

3.  Low-level infrared laser modulates muscle repair and chromosome stabilization genes in myoblasts.

Authors:  Larissa Alexsandra da Silva Neto Trajano; Ana Carolina Stumbo; Camila Luna da Silva; Andre Luiz Mencalha; Adenilson S Fonseca
Journal:  Lasers Med Sci       Date:  2016-05-25       Impact factor: 3.161

4.  LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

Authors:  Kuniaki Nakanishi; Hirotaka Matsuo; Yoshikatsu Kanai; Hitoshi Endou; Sadayuki Hiroi; Susumu Tominaga; Makio Mukai; Eiji Ikeda; Yuichi Ozeki; Shinsuke Aida; Toshiaki Kawai
Journal:  Virchows Arch       Date:  2005-09-21       Impact factor: 4.064

5.  Reduced expression of TRF1 is associated with tumor progression and poor prognosis in oral squamous cell carcinoma.

Authors:  Hui-Ching Chuang; Chang-Han Chen; Chao-Cheng Huang; Fu-Min Fang; Hsin-Ting Tsai; Chih-Yen Chien
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

6.  Androgen receptor interacts with telomeric proteins in prostate cancer cells.

Authors:  Sahn-Ho Kim; Michelle Richardson; Kannagi Chinnakannu; V Uma Bai; Mani Menon; Evelyn R Barrack; G Prem-Veer Reddy
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

7.  TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells.

Authors:  Annamaria Biroccio; Julien Cherfils-Vicini; Adeline Augereau; Sébastien Pinte; Serge Bauwens; Jing Ye; Thomas Simonet; Béatrice Horard; Karine Jamet; Ludovic Cervera; Aaron Mendez-Bermudez; Delphine Poncet; Renée Grataroli; Claire T'kint de Rodenbeeke; Erica Salvati; Angela Rizzo; Pasquale Zizza; Michelle Ricoul; Céline Cognet; Thomas Kuilman; Helene Duret; Florian Lépinasse; Jacqueline Marvel; Els Verhoeyen; François-Loïc Cosset; Daniel Peeper; Mark J Smyth; Arturo Londoño-Vallejo; Laure Sabatier; Vincent Picco; Gilles Pages; Jean-Yves Scoazec; Antonella Stoppacciaro; Carlo Leonetti; Eric Vivier; Eric Gilson
Journal:  Nat Cell Biol       Date:  2013-06-23       Impact factor: 28.824

Review 8.  Telomeric impact of conventional chemotherapy.

Authors:  Yiming Lu; Waiian Leong; Olivier Guérin; Eric Gilson; Jing Ye
Journal:  Front Med       Date:  2013-10-23       Impact factor: 4.592

9.  Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.

Authors:  Masahiro Kato; Masahiro Nakayama; Minako Agata; Kenichi Yoshida
Journal:  Tumour Biol       Date:  2012-12-18

10.  Clinical significance of telomere length and associated proteins in oral cancer.

Authors:  Rachana N Sainger; Shaila D Telang; Shilin N Shukla; Prabhudas S Patel
Journal:  Biomark Insights       Date:  2007-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.